FLURBIPROFEN DOC*ORAL SPRAY 15ML

FLURBIPROFEN DOC 0.25% mouthwash
FLURBIPROFEN DOC 0.25% oral spray
Equivalent medicine

What it is and what it is used for
FLURBIPROFEN DOC contains flurbiprofen, a non-steroidal anti-inflammatory and analgesic (pain-relieving) medicine that acts against inflammation and pain in the throat, mouth, and gums.
FLURBIPROFEN DOC is used in adults and adolescents over 12 years of age for the treatment of symptoms of pain and irritation of the gums, mouth, and throat (e.g., gingivitis, stomatitis, pharyngitis), including those resulting from conservative or extractive dental therapy (e.g., treatment of cavities or tooth extraction).
Consult your doctor if you do not feel better or if you feel worse after 3 days of treatment (see section 3).

What you need to know before taking the medicine
Do not use FLURBIPROFEN DOC
- if you are allergic to flurbiprofen or any of the other ingredients of this medicine (listed in section 6);
- if you are allergic to acetylsalicylic acid (a medicine for inflammation, pain, fever, and heart problems) or other non-steroidal anti-inflammatory drugs (NSAIDs) (see section Other medicines and FLURBIPROFEN DOC);
- if you have a history of stomach or intestinal bleeding or perforation related to previous NSAID treatments;
- if you suffer from chronic inflammatory bowel diseases (ulcerative colitis and Crohn's disease);
- if you frequently suffer from peptic ulcers (stomach lesions) or stomach or intestinal bleeding (two or more distinct episodes of ulcer or bleeding);
- if you suffer from severe heart failure (reduced heart function), severe liver failure (reduced liver function), and severe kidney failure (reduced kidney function).
Do not use FLURBIPROFEN DOC if you are in the last 3 months of pregnancy (see section Pregnancy and breastfeeding).
- if you are in the last three months of pregnancy.

Do not give FLURBIPROFEN DOC to children under 12 years of age.

Warnings and precautions
Consult your doctor or pharmacist before using FLURBIPROFEN DOC.
In particular, inform your doctor if:
- you have a history of bronchial asthma (a respiratory disease), as this increases the risk of bronchospasm (narrowing of the bronchi causing severe respiratory difficulty due to reduced air passage);
- you have a history of allergies;
- you are taking other Non-Steroidal Anti-inflammatory Drugs (NSAIDs);
- you suffer from systemic lupus erythematosus or mixed connective tissue disease;
- you suffer from reduced kidney, heart, or liver function (renal, cardiac, or hepatic insufficiency);
- you suffer from hypertension (high blood pressure);
- you are taking other analgesics for a long time or without respecting the dosage, as headaches may occur;
- you have a history of peptic ulcers (stomach lesions) and other stomach and intestinal diseases, as this increases the risk that these diseases may recur;
- you have an infection - refer to the Infections paragraph below.

Infections
Non-steroidal anti-inflammatory drugs (NSAIDs) can mask signs of infections such as fever and pain.
This can delay the appropriate treatment of the infection, which, in turn, can lead to an increased risk of complications. If you take this medicine during an infection and the symptoms of the infection persist or worsen, contact your doctor or pharmacist immediately.

This risk increases especially with high doses of flurbiprofen, if you are elderly, or if the peptic ulcer has been complicated by bleeding or perforation of the stomach and intestine (see section 4 Possible side effects);
- you are elderly (as you are more likely to experience side effects);
- you have heart or blood vessel problems, as medicines like FLURBIPROFEN DOC may be associated with a modest increased risk of heart attack (myocardial infarction) or stroke. The risk of side effects increases with high doses and prolonged treatments; do not exceed the dose of FLURBIPROFEN DOC and do not use it for long periods. Inform your doctor if you have heart problems, a history of stroke, or think you may be at risk for these conditions (for example, if you have high blood pressure, diabetes, high cholesterol, or smoke).
Report any unusual abdominal symptoms to your doctor. The use of this medicine, especially if prolonged, can give rise to allergic phenomena or local irritation (see section 4 Possible side effects); in such cases, stop treatment and consult your doctor who, if necessary, will carry out appropriate therapy.
If you experience mouth irritation, stop treatment.

Children and adolescents
Do not give FLURBIPROFEN DOC to children under 12 years of age.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everyone gets them.

- If you experience the following side effects during treatment with FLURBIPROFEN DOC, STOP treatment and contact your doctor immediately: allergic phenomena (sensitization phenomena):
- allergic reaction
- anaphylactic reactions (severe allergic reactions)
- angioedema (sudden swelling of the mouth/throat and mucous membranes)
- local irritation
- respiratory phenomena: asthma, bronchospasm, wheezing or shortness of breath
- various skin disorders: skin rashes of different types, itching, redness, swelling, skin loss, blisters, desquamation or ulceration of the skin and mucous membranes.

If you experience the following side effects at the beginning of treatment with FLURBIPROFEN PENSA, contact your doctor immediately:
- abdominal pain
- peptic ulcer (stomach lesion) - perforation and bleeding of the stomach or intestine. These side effects can be fatal and may occur with or without warning symptoms. These side effects occur especially if you are elderly or if you have a history of stomach and intestinal diseases.

In addition, you may experience the following side effects:

Effects affecting the blood
- anemia (reduction in the number of red blood cells in the blood)
- thrombocytopenia (reduction in the number of platelets in the blood)
- aplastic anemia (reduction in the number of all types of blood cells, red blood cells, white blood cells, platelets)
- agranulocytosis (reduction in the number of granulocytes, a type of white blood cell, in the blood).

Effects affecting the nervous system
- dizziness
- headache
- paraesthesia (numbness of the limbs or other parts of the body)
- drowsiness
- cerebrovascular accidents (diseases caused by lack of blood flow to an area of the brain)
- visual disturbances
- optic neuritis (severe inflammation of the optic nerve, which can lead to reduced vision up to blindness)
- migraine (chronic disease characterized by recurrent headaches)
- confusion
- vertigo.

Effects affecting the immune system
- anaphylactic reactions (severe allergic reaction)
- angioedema (inflammatory skin reaction)
- hypersensitivity.

Effects affecting the eye
- visual disturbances.

Effects affecting the ear and labyrinth
- tinnitus (ringing in the ears).

Effects affecting the cardiovascular system
- heart failure
- swelling
- hypertension (high blood pressure)

Effects affecting the bronchi and lungs
- throat irritation
- asthma
- bronchospasm (narrowing of the bronchi causing severe respiratory difficulty due to reduced air passage)
- dyspnea (shortness of breath)
- blisters in the mouth or throat
- numbness of the mouth or throat.

Effects affecting the mouth, stomach and intestines
- diarrhea
- lesions inside the mouth
- nausea
- mouth and throat pain
- abdominal distension
- abdominal pain
- constipation
- dry mouth
- indigestion
- flatulence (passing gas from the intestines)
- inflammation of the tongue
- altered taste
- vomiting
- blood in the stool
- blood in vomit
- bleeding from the stomach and intestines
- colitis
- worsening of inflammatory bowel diseases (Crohn's disease)
- gastritis (inflammation of the stomach)
- peptic ulcer
- gastric perforation.

Effects affecting the skin and subcutaneous tissue
- skin rash
- itching
- urticaria (skin redness accompanied by itching) purpura (appearance of purplish skin patches of different sizes)
- bullous dermatoses (severe skin lesions characterized by erythema, bullous lesions with areas of skin detachment), including Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis and erythema multiforme.

Effects affecting the kidneys and urinary tract
- renal toxicity
- tubulointerstitial nephritis (inflammation of the kidneys)
- nephrotic syndrome (alteration of the renal glomeruli leading to protein loss in the urine)
- renal failure (reduced kidney function).

General effects and effects at the administration site
- fever
- pain
- discomfort
- fatigue

Effects affecting the liver
- hepatitis

Effects affecting the psychiatric sphere
- insomnia
- depression
- hallucination.

Reporting of side effects
If you get any side effects, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.